NOT FOR DISTRIBUTION
Header cover image

Market Cap

Rp6.7t

Last Updated

2021/05/10 17:43 UTC

Data Sources

Company Financials

Executive Summary

PT Soho Global Health Tbk operates as a healthcare company in Indonesia. More Details

Rewards

Trading at 93.3% below our estimate of its fair value

Earnings grew by 43.7% over the past year

Risk Analysis

No risks detected for SOHO from our risk checks.


Snowflake Analysis

Flawless balance sheet with acceptable track record.

Share Price & News

How has Soho Global Health's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SOHO is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: SOHO's weekly volatility has decreased from 15% to 4% over the past year.


Market Performance


7 Day Return

10.3%

SOHO

1.3%

ID Pharmaceuticals

-0.5%

ID Market


1 Year Return

n/a

SOHO

20.4%

ID Pharmaceuticals

22.3%

ID Market

Return vs Industry: Insufficient data to determine how SOHO performed against the ID Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how SOHO performed against the ID Market.


Shareholder returns

SOHOIndustryMarket
7 Day10.3%1.3%-0.5%
30 Day14.6%-3.8%-2.7%
90 Day6.1%-9.1%-5.5%
1 Yearn/a22.7%20.4%26.3%22.3%
3 Yearn/a2.3%-3.3%2.3%-5.4%
5 Yearn/a32.9%20.3%34.1%17.8%

Long-Term Price Volatility Vs. Market

How volatile is Soho Global Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Soho Global Health undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: SOHO (IDR5250) is trading below our estimate of fair value (IDR78189.3)

Significantly Below Fair Value: SOHO is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: SOHO is poor value based on its PE Ratio (27.5x) compared to the ID Pharmaceuticals industry average (25x).

PE vs Market: SOHO is poor value based on its PE Ratio (27.5x) compared to the ID market (22.4x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SOHO's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SOHO is overvalued based on its PB Ratio (3x) compared to the ID Pharmaceuticals industry average (2.4x).


Future Growth

How is Soho Global Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

18.4%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Soho Global Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Soho Global Health performed over the past 5 years?

43.7%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: SOHO has high quality earnings.

Growing Profit Margin: SOHO's current net profit margins (2.8%) are higher than last year (2.4%).


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if SOHO's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare SOHO's past year earnings growth to its 5-year average.

Earnings vs Industry: SOHO earnings growth over the past year (43.7%) exceeded the Pharmaceuticals industry 9%.


Return on Equity

High ROE: SOHO's Return on Equity (7.8%) is considered low.


Financial Health

How is Soho Global Health's financial position?


Financial Position Analysis

Short Term Liabilities: SOHO's short term assets (IDR3,406.0B) exceed its short term liabilities (IDR1,797.4B).

Long Term Liabilities: SOHO's short term assets (IDR3,406.0B) exceed its long term liabilities (IDR176.7B).


Debt to Equity History and Analysis

Debt Level: SOHO is debt free.

Reducing Debt: SOHO had no debt 5 years ago.

Debt Coverage: SOHO has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: SOHO has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Soho Global Health current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SOHO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SOHO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SOHO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SOHO's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SOHO's dividend in 3 years as they are not forecast to pay a notable one for the ID market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Soho Global Health has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: SOHO only recently listed within the past 12 months.


Top Shareholders

Company Information

PT Soho Global Health Tbk's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: PT Soho Global Health Tbk
  • Ticker: SOHO
  • Exchange: IDX
  • Founded: NaN
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: Rp6.663t
  • Shares outstanding: 1.27b
  • Website: https://www.sohoglobalhealth.com

Number of Employees


Location

  • PT Soho Global Health Tbk
  • JL. Rawa Sumur II Kav BB No. 3
  • awasan Industri Pulogadung, Kel. Jatinegara, Kec. Cakung
  • Jakarta Timur
  • Jakarta Raya
  • Indonesia

Listings


Biography

PT Soho Global Health Tbk operates as a healthcare company in Indonesia. The company researches, develops, and markets specialty-focused medicines for use in the therapeutic areas of immunomodulator, respi...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/10 17:43
End of Day Share Price2021/05/07 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.